July 2005
Computed tomographic colonoscopy can detect
cancer outside of colon
The investigation of the colon using computed tomography can detect cancers
and other important conditions outside of the colon. Conventional
colonoscopy only examines the inside of the colon and would therefore miss
these. 28 July 2005
Magnetic resonance spectroscopy improves
identification of cancerous breast tumours
A study published in the August issue of Radiology shows that adding
spectroscopic analysis to magnetic resonance (MR) imaging increased both the
detection rate of cancerous tumours and the success rate of distinguishing
benign from malignant tumours. 28 July 2005
Laser and fibre optics could help early cancer
detection
A novel technology using an optical fibre to carry laser light into
suspicious tissue and performing spectral analysis of the cells, could help
detect cancer earlier, without performing invasive biopsies. 27 July 2005
St Jude Medical's remote patient monitoring
system receives FDA approval
The new version of software for the St Jude Medical's Housecall Plus remote
patient monitoring system has received approval from the United States FDA.
The system monitors implantable cardioverter defibrillator (ICD) patients.
21 July 2005
Space Shuttle astronauts' health on space walks
monitored with GE technology
The health of the astronauts will be monitored in real time during
space walks using GE Healthcare's advanced monitoring and networking
technology. 21 July 2005
PET scans better than CT in detection of
vaginal cancer
In patients with vaginal cancer, PET scans detected twice as many primary
tumours and cancerous lymph nodes as did CT scans, according to researchers
at Washington University School of Medicine in St. Louis. 21 July 2005
Record financial results for GE in second
quarter 2005
GE achieved record second-quarter earnings of $4.6 billion, 24% higher than
second quarter 2004, on 13% growth in revenues to $41.6 billion, the Company
announced on 15 July 2005. First-half cash flow from operating activities (CFOA)
of $8.0 billion rose 18%, with CFOA of GE's industrial businesses up 24%. 17
July 2005
Insight into cell metabolism will help
interpret PET, MRI scans
By discovering a crucial piece of submicroscopic information about how the
brain converts fuel into energy for neurons, Cornell University
biophysicists have gleaned new insights into brain cell metabolism that will
allow neurologists to better interpret data from such diagnostic tests as
PET scans and blood oxygen level dependent functional magnetic resonance
imaging (BOLD-fMRI) scans. 13 July 2005
New computer program uses brain scans to assess
risk of Alzheimer’s
New York University School of Medicine researchers have developed a brain
scan-based computer program that quickly and accurately measures metabolic
activity in a key region of the brain affected in the early stages of
Alzheimer’s disease. 13 July 2005
PET scans miss up to eight percent of cancers
Up to 8% of cancerous lesions occur outside the current imaging field.
Whole-body scanning using combined PET/CT is needed to ensure proper
diagnosis and treatment of cancer. 13 July 2005
Caffeine and exercise can prevent clear PET and
CT imaging of heart
Consumption of caffeine before a positron emission tomography (PET) or
computed tomography (CT) scan of the heart can increase the amount of
chemical tracer in the heart and obscure the images. If a person exercises
or drinks coffee before having a PET/CT scan, the heart beats faster,
causing more tracer to appear in the heart region, obscuring the view. 13
July 2005
Scotland's support for life sciences and
medical technology paying off
Scotland's strategy to build foreign direct investment in life sciences and
technology through a comprehensive government, academic and private
corporate support infrastructure strategy seems to have paid off after just
a few years. 12 July 2005
Roche and GE Healthcare collaborate to develop
personalised medicine for Alzheimer's patients
Roche and GE Healthcare, have announced a collaboration aimed at developing
personalised care for patients with Alzheimer's disease. In controlled
clinical trials, patients taking a Roche anti-amyloid drug candidate for
Alzheimer's disease will be monitored clinically for drug response using
GE's positron emission tomography (PET) diagnostic imaging agent. 11 July
2005
Roche und GE Healthcare werden
personalisierte Medizin für Alzheimer-Patienten erforschen. 11 Juli 2005
Roche e GE Healthcare
esploreranno la medicina personalizzata in pazienti affetti dal morbo di
Alzheimer. 11 luglio 2005
Roche et
GE Healthcare vont explorer la médecine personnalisée pour les patients
atteints de la maladie d’Alzheimer. 11 Juillet 2005
Philips to acquire leading US PACS supplier
Stentor
Royal Philips Electronics and Stentor Inc. have announced that Philips will
acquire Stentor, a leading US PACS supplier. The Merger strengthens Philips'
presence in the high-growth healthcare information technology market by
enabling it to give a more complete package of products. The geographic
reach of Stentor also complements that of Philips. 8 July 2005
Heart monitoring device lets patients record
their own ECG
A new handheld monitoring device launched by Trident International
Corporation lets patients record their electrocardiogram (ECG) anytime and
anywhere. The ReadMyHeart captures information vital to better
cardiovascular disease management n only 30 seconds. 6 July 2005
First implants of Medtronic Adapta pacemaker
for slow heart rhythm
Medtronic has started clinical studies to evaluate its Adapta pacemaker in
Serbia, Germany and Austria. Within the next year, Medtronic expects to
introduce a portfolio of fully automatic pacemakers, the Adapta, Versa, and
Sensia, in countries worldwide. 6 July 2005
New Philips MRI research centre targets
Alzheimer's and Parkinson's
Philips Medical Systems has opened a new ultra high field magnetic resonance
imaging (MRI) research centre at its Cleveland facility. The Philips Achieva
7.0T (tesla) research system is aimed at improving MRI capabilities,
particularly for the study of degenerative neurological diseases. 6
July 2005
Combined PET/CT scanner from GE brings promise
of earlier disease detection
GE Healthcare has introduced the Discovery STE, a new molecular imaging
system designed to help doctors detect, diagnose and monitor treatment of
cancer and other diseases, including heart disease and neurological disease,
more accurately and earlier in the disease process. 5 July 2005
Biofeedback device for improving gait
Andante Medical Devices Ltd has released its first product, SmartStep, to
improve the gait of patients undergoing rehabilitation during recovery from
neurological, orthopaedic, and other disorders affecting the lower limb. 5
July 2005
Implantable pain therapy device receives FDA
approval
The SynergyPlus+ is the newest "pain pacemaker" to join Medtronic's family
of implantable chronic pain therapies. It was designed to give patients more
control over the delivery of stimulation that blocks pain signals from
reaching the brain while performing a variety of daily activities. 4 July
2005
More news...
News home
2005
Jan |
Feb |
Mar |
Apr |
May | Jun | Jul | Aug |
Sep | Oct
To top
|